Find similar content

Source channel @githubtrending · Post #15367 · Dec 25

#cplusplus#arduino#ble_jammer#ble_spoof#ble_spoofer#cybersecurity#deauther#esp32#hack#hacktoberfest#jammer#nrf_scanner#nrf24l01#sour_apple nRFBOX is a handheld ESP32-based tool that scans and analyzes the 2.4 GHz band (Wi‑Fi, BLE, etc.), shows signal strength and channel activity, and can run jamming, BLE jamming/spoofing, and Wi‑Fi deauthentication tests for security research and troubleshooting. It combines an ESP32, NRF24 modules, OLED display, battery management, and SD support for firmware and logging, with notes about limited range, device variability, and power limits when using multiple NRF modules. Benefit: you can use it to find crowded channels, diagnose wireless interference, and test network/device resilience in controlled, legal test environments. https://github.com/cifertech/nRFBox

Hashtags

#cplusplus #arduino #ble_jammer #ble_spoof #ble_spoofer #cybersecurity #deauther #esp32 #hack #hacktoberfest #jammer #nrf_scanner #nrf24l01 #sour_apple

Results

2 similar posts found

Search: #drugdevelopment

当前筛选 #drugdevelopment清除筛选

Crypto M - Crypto News

@CryptoM · Post #64470 · 04/09/2026, 01:45 AM

Find similar View

🚀 Hong Kong's Innovative Drug Sector Gains Momentum Hong Kong's innovative drug sector is experiencing a surge, with several companies showing significant gains. According to Jin10, Ascletis Pharma (01672.HK) saw an increase of over 3%, while Hansoh Pharmaceutical (03692.HK) rose by more than 2%. Other companies such as WuXi AppTec (02359.HK) and Sihuan Pharmaceutical (00460.HK) also followed suit with upward trends. #HongKong#Pharmaceuticals#Biotech#Innovation#StockMarket#Healthcare#DrugDevelopment

Hashtags

#hongkong #pharmaceuticals #biotech #innovation #stockmarket #healthcare #drugdevelopment

Venture Village Wall 🦄

@venturevillagewall · Post #3642 · 12/21/2024, 10:23 AM

Find similar View

PeproMene Bio Secures $11M Round PeproMene Bio, Inc., a clinical-stage biotech firm based in Irvine, CA, has successfully raised $11 million in funding. The investment round closed on December 18, 2024, focusing on innovative therapies targeting cancers and immune disorders. More info: PeproMene Bio #Biotech#Funding#Cancer#ImmuneDisorders#California#ClinicalStage#Therapies#Investment#Healthcare#Innovation#PeproMeneBio#Pharmaceuticals#MedicalResearch#DrugDevelopment

Hashtags

#biotech #funding #cancer #immunedisorders #california #clinicalstage #therapies #investment #healthcare #innovation #pepromenebio #pharmaceuticals #medicalresearch #drugdevelopment